about
Targeting membrane proteins for antibody discovery using phage display.Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10.Nanocell targeting using engineered bispecific antibodies.Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cellsHeat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.Insights into the interfacial structure-function of poly(ethylene glycol)-decorated peptide-stabilised nanoscale emulsions.Bispecific Antibody-Functionalized Upconversion Nanoprobe.Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.Biosensing made easy with PEG-targeted bi-specific antibodies.Functional domain analysis of SOX18 transcription factor using a single-chain variable fragment-based approach.Biosimilars approved for treatment of inflammatory rheumatological diseases.Multiplexed SERS Detection of Soluble Cancer Protein Biomarkers with Gold-Silver Alloy Nanoboxes and Nanoyeast Single-Chain Variable FragmentsEnhanced uptake of potassium or glycine betaine or export of cyclic-di-AMP restores osmoresistance in a high cyclic-di-AMP Lactococcus lactis mutantA SERS microfluidic platform for targeting multiple soluble immune checkpointsRNA interference to enhance radiation therapy: Targeting the DNA damage responseS-Trap Eliminates Cell Culture Media Polymeric Surfactants for Effective Proteomic Analysis of Mammalian Cell Bioreactor SupernatantsSingle droplet detection of immune checkpoints on a multiplexed electrohydrodynamic biosensorRetooling phage display with electrohydrodynamic nanomixing and nanopore sequencingWavelength-Dependent Fluorescent Immunosensors via Incorporation of Polarity Indicators near the Binding Interface of Antibody FragmentsCellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter?Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesMultifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy
P50
Q36020577-62961E3E-9677-47B3-99BC-0533DB4895BCQ36080388-1B6B7FB0-DAC1-4596-9062-E018B7039CBFQ36200871-FD7CE418-29B6-41A1-BD24-AC36E4DF6DF5Q36211456-5025BFB3-463C-4F80-97AB-B03FD7A2762EQ36907352-5388AAB2-1A5B-444F-BA51-2AAC072C7A4DQ40491294-0F8C475F-BDB9-499A-8E8B-F60B48B31BBDQ47107902-5A250964-5194-40A4-A603-367CF11FA6D2Q47725919-E3915725-06F6-44A5-80A7-A0813AFE156DQ47840214-0840C6CB-A256-4200-BCDB-107F6BF7219FQ50005131-F6A9341F-013C-4F6D-9607-CA63B14DD9F4Q50048109-A8758041-95CF-4A20-AFC9-6FAC66B5E707Q51297471-8E2A465D-8A49-4F15-8FF2-D969CF362B94Q51393032-D7436613-F434-492A-A1BB-DF423E0485E1Q52323683-C37515B2-A9AA-47EC-8CE5-B2F7B91B9AEFQ53604274-02F8A56A-624B-4D81-B11C-D6C8A31DBA36Q57132638-9F6AAC6E-78DD-454A-9789-49C8AEF1015AQ57252647-776E1517-677E-4002-97E6-640F71116B37Q58552914-B5B6827F-4381-41F2-B645-5C33F774E5A7Q58988725-727B6359-16A2-4ECD-8B30-26D4E39C13D2Q90620544-CF743430-F615-405D-98F9-9069088C4B63Q90966665-4583701E-7E40-4AFF-B861-19145DE99A07Q91236390-93E2DCA7-9BFD-4EE9-A927-7A2D3B839073Q92220396-0BACBA76-B58B-4651-9141-51F09C1BD545Q92338021-E83A3C75-438B-4590-855B-2494A8E4EAB6Q92348910-0A23C978-5609-4D2E-A575-AC4B602E82B2Q92721639-FC5ABC61-5057-458E-875D-87C04287B076
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher B Howard
@nl
Christopher B Howard
@sl
Christopher B. Howard
@en
Christopher B. Howard
@es
كريستوفر بي. هوارد
@ar
type
label
Christopher B Howard
@nl
Christopher B Howard
@sl
Christopher B. Howard
@en
Christopher B. Howard
@es
كريستوفر بي. هوارد
@ar
altLabel
Chris Howard
@en
prefLabel
Christopher B Howard
@nl
Christopher B Howard
@sl
Christopher B. Howard
@en
Christopher B. Howard
@es
كريستوفر بي. هوارد
@ar
P1053
D-3859-2017
P106
P1153
56379620200
P21
P31
P3829
P496
0000-0001-9797-8686